Assignee
CAPTOR THERAPEUTICS S A
PL·0 granted patents·5 pending applications·0 citations·filing 2020–2022
Top patents by PatentIndex Score
5 records- 0149US2024294499A1Targeted protein degradation using bifunctional compounds that bind ubiquitin ligase and target mcl-1 proteinCAPTOR THERAPEUTICS S A·Filed 2022·Application pending·0 cites
- 0246US2024307547A1Novel compounds which bind to cereblon, and methods of use thereofCAPTOR THERAPEUTICS S A·Filed 2021·Application pending·0 cites
- 0344US2024294489A1Low molecular weight protein degraders and their applicationsCAPTOR THERAPEUTICS S A·Filed 2021·Application pending·0 cites
- 0442US2024343706A1Piperidine-2,6-dione derivatives which bind to cereblon, and methods of use thereofCAPTOR THERAPEUTICS S A·Filed 2020·Application pending·0 cites
- 0542US2023065745A1Piperidine-2,6-dione derivatives which bind to cereblon, and methods of use thereofCAPTOR THERAPEUTICS S A·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CAPTOR THERAPEUTICS S A files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →